New report by The Lancet released Wednesday has suggested adopting measures apart from body mass index (BMI) to determine excess body fats in individuals and to define obesity.
On the surface, problems with weight may seem simple – the body stores excess energy from food as fat. But the reality is that obesity is a complex chronic disease which can be caused by many interlinked factors.
Survey emphasises a balanced and diverse diet to deal with the burgeoning obesity problem. It also recognises mental health as a principal factor in individual & national development.
Tirzepatide is a type 2 diabetes and obesity drug sold by US firm Eli Lilly under the brand names Mounjaro and Zepbound. It may take around 6 months for it to be launched in India.
Study, conducted by NCD Risk Factor Collaboration & WHO, shows that nearly 880 million adults globally living with obesity in 2022 — 4.5 times higher than the number recorded in 1990.
Study by Australian & Canadian scientists, published in Kidney International, finds that drug may be effective at reducing inflammation — lowering risk of heart & kidney disease.
In clinical trials, tirzepatide by Eli Lilly has shown to reduce body weight by up to 22.5 percent, on average, after about 72 weeks, according to the company.
After exuberance, India must now not only take difficult and costly steps toward industrialisation, but also convert growth into geo-economic leverage and military modernisation.
WEF report flags growing erosion of multilateralism, long considered stabilising force. 'Declining trust, heightened protectionism are threatening trade, investment.'
Pakistan lacks capacity to deliver aircraft at pace suggested by its claimed contracts as it depends on China for avionics, electronic warfare, weapons, and on Russia for engines.
UK, EFTA already in the bag and EU on the way, many members of RCEP except China signed up, and even restrictions on China being lifted, India has changed its mind on trade.
COMMENTS